Amarin | AMRN - Market Capitalization


Amarin reported $305.2M in Market Capitalization this April of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 403.83B 5.2B Dec/2025
Alnylam Pharmaceuticals USD 52.54B 7.24B Dec/2025
Amarin USD 290M 51M Dec/2025
AstraZeneca USD 288.15B 55.08B Dec/2025
BioCryst Pharmaceuticals USD 1.66B 64M Dec/2025
DBV Technologies USD 274M 17M Sep/2025
Esperion Therapeutics USD 885M 351M Dec/2025
GlaxoSmithKline GBP 74.36B 10.31B Dec/2025
Halozyme Therapeutics USD 7.91B 664M Dec/2025
Heron Therapeutics USD 238M 7M Dec/2025
Ionis Pharmaceuticals USD 12.81B 2.39B Dec/2025
Nektar Therapeutics USD 14.34B 13.48B Apr/2026
Neurocrine Biosciences USD 14.14B 218M Dec/2025
Novartis USD 292.21B 26.55B Dec/2025